ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota
Mingyang Cheng(Jilin Agricultural University), Xin Cao(Jilin Agricultural University)
Cited by 6
Related Papers
The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation
|Cell Death and Differentiation|2024|8
E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0